Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Obesity-Related Chronic Kidney Disease: Principal Mechanisms and New Approaches in Nutritional Management
Alessandra Stasi, Carmela Cosola, Gianvito Caggiano, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

The Related Metabolic Diseases and Treatments of Obesity
Ming Yang, Shuai Liu, Chunye Zhang
Healthcare (2022) Vol. 10, Iss. 9, pp. 1616-1616
Open Access | Times Cited: 78
Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases
Reddemma Sandireddy, Suganya Sakthivel, Priyanka Gupta, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 27
The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes
Merlin C. Thomas, Melinda T. Coughlan, Mark E. Cooper
Cell Metabolism (2023) Vol. 35, Iss. 2, pp. 253-273
Open Access | Times Cited: 33
Cardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD)
Mariam M. Ali, Sanober Parveen, Vanessa Williams, et al.
Journal of Clinical & Translational Endocrinology (2024) Vol. 36, pp. 100341-100341
Open Access | Times Cited: 9
Obesity-Related Kidney Disease: Current Understanding and Future Perspectives
Frederik Flindt Kreiner, Philip Andreas Schytz, Hiddo J.L. Heerspink, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2498-2498
Open Access | Times Cited: 15
The Fat Kidney
Ludovica Verde, Stefania De Luca, Simona Cernea, et al.
Current Obesity Reports (2023) Vol. 12, Iss. 2, pp. 86-98
Open Access | Times Cited: 14
Novel Therapeutic Approaches in the Management of Chronic Kidney Disease
Bartłomiej Dąbek, Jill Dybiec, Weronika Frąk, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2746-2746
Open Access | Times Cited: 11
Non-linear relationship between body roundness index and albuminuria among children and adolescents aged 8–19 years: A cross-sectional study
Xuankai Qin, Jiahui Wei, Jie Chen, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0299509-e0299509
Open Access | Times Cited: 4
Exploring Adiposity and Chronic Kidney Disease: Clinical Implications, Management Strategies, Prognostic Considerations
Laşin Özbek, Sama Mahmoud Abdel‐Rahman, S. Ünlü, et al.
Medicina (2024) Vol. 60, Iss. 10, pp. 1668-1668
Open Access | Times Cited: 4
Targeting endoplasmic reticulum stress: an innovative therapeutic strategy for podocyte-related kidney diseases
Jiao Lv, Haiying Yu, Shaojun Du, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Agomelatine Mitigates Kidney Damage in Obese Insulin-Resistant Rats by Inhibiting Inflammation and Necroptosis via the TNF-α/NF-ĸB/p-RIPK3 Pathway
Sasivimon Promsan, Nattavadee Pengrattanachot, Nichakorn Phengpol, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1940-1940
Open Access
Postbiotics and their biotherapeutic potential for chronic disease and their feature perspective: a review
Zerihun Asefa, Abera Belay, Eyuel Welelaw, et al.
Frontiers in Microbiomes (2025) Vol. 4
Open Access
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Exploring Systemic Impacts and Innovative Therapies
Parag Jain, Akanksha Jain, Rohitas Deshmukh, et al.
Clinics and Research in Hepatology and Gastroenterology (2025), pp. 102584-102584
Closed Access
Gut-Derived Uremic Toxins in CKD: An Improved Approach for the Evaluation of Serum Indoxyl Sulfate in Clinical Practice
Gianvito Caggiano, Loredana Amodio, Alessandra Stasi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5142-5142
Open Access | Times Cited: 10
Are we ready for an adipocentric approach in people living with type 2 diabetes and chronic kidney disease?
Óscar Moreno, Rebeca Reyes‐García, Inés Modrego Pardo, et al.
Clinical Kidney Journal (2024) Vol. 17, Iss. 4
Open Access | Times Cited: 3
Advances in Oral Biomacromolecule Therapies for Metabolic Diseases
Qiuxia Jiao, Yuan Huang, Jinhan He, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 238-238
Open Access
Apigenin Ameliorates Insulin Resistance in 3T3‐L1 Adipocytes: Establishment of a New Insulin Resistance Model Induced by Combined Treatments
Xiaoxuan Guo, Bing Xia, Sha Liu, et al.
Molecular Nutrition & Food Research (2025)
Open Access
Alterations of the gut microbiota in patients with diabetic nephropathy and its association with the renin-angiotensin system
Fatemeh Zali, Abdorrahim Absalan, Golnaz Bahramali, et al.
Journal of Diabetes & Metabolic Disorders (2025) Vol. 24, Iss. 1
Closed Access
Electrolyte Imbalances and Metabolic Emergencies in Obesity: Mechanisms and Clinical Implications
Iulia Najette Crintea, Alexandru Cristian Cindrea, Ovidiu Alexandru Mederle, et al.
Diseases (2025) Vol. 13, Iss. 3, pp. 69-69
Open Access
Ultra-processed foods and risk of declined renal function: a dose–response meta-analysis of 786,216 participants
Mohammad Ali Hojjati Kermani, Farhang Hameed Awlqadr, Sepide Talebi, et al.
Journal of Health Population and Nutrition (2025) Vol. 44, Iss. 1
Open Access
A cross-sectional study investigating the L-shaped relationship between urinary albumin creatinine ratio and overweight/obesity in children and adolescents
Zhengjiu Cui, Xiaorui Chen, Shengchun Zhai, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Correlation between conventional and unconventional lipid parameters with the risk of progression of renal function decline: insights from the China Health and Retirement Longitudinal Study 2011–2015
Yijing Xin, Yimeng Wang, Yuyuan Shu, et al.
Renal Failure (2025) Vol. 47, Iss. 1
Open Access
Cordyceps guangdongensis lipid-lowering formula alleviates fat and lipid accumulation by modulating gut microbiota and short-chain fatty acids in high-fat diet mice
Gangzheng Wang, Chengyuan Sun, Bojun Xie, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 14
Glomerular hyperfiltration and hypertrophy: an evaluation of maximum values in pathological indicators to discriminate “diseased” from “normal”
Hiroshi Kataoka, Kosaku Nitta, Junichi Hoshino
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 7
Folate Deficiency Enhanced Inflammation and Exacerbated Renal Fibrosis in High-Fat High-Fructose Diet-Fed Mice
C. W. Chan, Bi‐Fong Lin
Nutrients (2023) Vol. 15, Iss. 16, pp. 3616-3616
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top